Close Menu

The discussion that started with a federal court overturning two gene patents continues as the biotech industry, researchers and lawyers debate the merits of the decision, the chances of an appeal, and the future of genetic research. As the debate continues, some say it's not really a big deal, and the emerging consensus is that this ruling may actually be a good thing if it forces companies to think outside the patent box and start innovating again.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.